Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: A multivariate analysis

Journal of Affective Disorders

Volumn 47, Issue 1-3, 1998, Pages 71-79

  Hylan, Timothy R ^a,b,c   Crown, William H ^d   Meneades, Laurie ^d   Heiligenstein, John H ^a   Melfi, Catherine A ^a,e,f   Croghan, Thomas W ^a,e   Buesching, Don P ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MIAMI UNIVERSITY   (United States)

^d MEDSTAT GROUP   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f REGENSTRIEF INSTITUTE   (United States)

Author keywords

Depression; Health care costs; Selective serotonin reuptake inhibitors; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; LITHIUM; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ARTICLE; DEPRESSION; DRUG COST; DRUG PREFERENCE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MENTAL DISEASE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

1-NAPHTHYLAMINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DIRECT SERVICE COSTS; DRUG COSTS; FEE-FOR-SERVICE PLANS; FEMALE; FLUOXETINE; HEALTH CARE COSTS; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MODELS, ECONOMETRIC; MULTIVARIATE ANALYSIS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; UNITED STATES;

EID: 0031888640     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00120-1     Document Type: Article

References (20)

1. Agency for Health Care Policy Research, 1993. Treatment of major depression: clinical practice guidelines. US Department of Health and Human Services, AHCPR Publication No. 93 -0550, Rockville, MD.
2. Bisserbe, J.C., Boyer, P., Soutre, E., 1996. A six month sertraline fluoxetine comparison study in depressed outpatients: outcomes and costs [abstract no. 0-19-6]. Eur. Col. Neuropsychopharm. 6 (3), 142.
3. Coupland, N.J., Bell, C.J., Potokar, J.P., 1996. Serotonin reuptake inhibitor withdrawal. J. Clin. Psychopharm. 16 (3), 356-362.
4. Forder, J., Kavanagh, S., Fenyo, A., 1996. A comparison of the cost-effectiveness of sertraline vs. tricyclic antidepressants in primary care. J. Affect. Disord. 38, 87-111.
5. Greenberg, P., Stiglin, L.E., Finkelstein, S., 1993. The economic burden of depression in 1990. J. Clin. Psych. 54 (11), 405-418.
6. Greene, W.H., 1994. Econometric Analysis. MacMillan, New York, NY.
7. Greene, W.H., 1995. LIMDEP, Vol. 7. Econometric Software, New York, NY
8. Gregor, K., Overhage, J.M., Coon, S.J., McDonald, R., 1994. Selective serotonin reuptake inhibitor dose titration in a naturalistic setting. Clin. Ther. 16 (2), 306-315.
9. Guze, B., 1996. Selective serotonin reuptake inhibitors: assessment for formulary inclusion. Pharmacoecon. 9 (5), 430-442.
10. Heckman, J., Smith, J., 1995. Assessing the case for social experiments. J. Econ. Persp. 9 (2), 85-110.
11. Lee, L.F., 1983. Generalized models with selectivity. Econometrica 51, 507-512.
12. Murnane, R., Newstead, S., Olsen, R., 1985. Comparing public and private schools: the puzzling role of selectivity bias. J. Bus. Econ. Stat. 3 (1), 23-35.
13. Sclar, D.A., Robison, L.M., Skaer, T.L., Legg, R.F., Nemec, N.L., Galin, R.S., Hughes, T.E., Buesching, D.P., 1994. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin. Ther. 16 (4), 715-730.
14. Sclar, D.A., Robison, L.M., Skaer, T. et al., 1995. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine, and sertraline in a health maintenance organization. J. Int. Med. Res. 23, 395-412.
15. Simon, G.E., 1995. Cost-effectiveness comparisons using 'real-world' randomized trials: the case of new antidepressants. J. Clin. Epi. 48, 363-373.
16. Simon, G.E., Von Korff, M., Heiligenstein, J.H., Revicki, D.A., Grothaus, L., Katon, W., Wagner, E.H., 1996. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs. tricyclic antidepressants. J. Am. Med. Assoc. 275 (24), 1897-1902.
17. Skaer, T.L., Sclar, D.A., Robison, L., 1995. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression. Cur. Ther. Res. 56 (6), 556-567.
18. Stokes, P.E., 1993. Fluoxetine: a five-year review. Clin. Ther. 15, 216-243.
19. Thompson, D., Buesching, D., Gregor, K., Oster, G., 1996. Patterns of antidepressant use and their relation to costs of care. Am. J. Man. Care 2 (9), 1239-1246.
20. Von Korff, M., Wagner, E.H., Saunders, K., 1992. A chronic disease score from automated pharmacy data. J. Clin Epi. 45 (2), 197-203.